NanoViricides
NNVC
17 hedge funds and large institutions have $247K invested in NanoViricides in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 21 closing their positions.
700% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 1
2.94% more ownership
Funds ownership: 0.2% → 3.13% (+2.9%)
53% less funds holding
Funds holding: 36 → 17 (-19)
66% less capital invested
Capital invested by funds: $731K → $247K (-$484K)
90% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$17.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.36K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.34K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.8K |
| 5 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$1.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$42K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$26K |
| 3 |
PTB
Pioneer Trust Bank
Salem,
Oregon
|
-$24K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$17K |
| 5 |
SCA
STALEY CAPITAL ADVISERS
Pittsburgh,
Pennsylvania
|
-$14K |
NNVC Hedge Fund Activity: Q3 2019 in Review
17 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2019, worth a combined $247K — down 66% from $731K a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of NNVC and 2 opened new positions — a net loss of 19 holders — while 1 trimmed existing stakes and 8 added.
The largest buyer was Renaissance Technologies, adding an estimated $17.6K. The largest seller was Geode Capital Management, exiting entirely with an estimated $42K sold.
- 17 institutional investors held NanoViricides (NNVC) as of Q3 2019, down from 36 in Q2 2019.
- Funds reported $247K of NanoViricides stock for Q3 2019, down 66% quarter-over-quarter.
- 2 funds opened new NanoViricides positions in Q3 2019 and 21 closed out, a net change of -19 holders.
- The largest NanoViricides buyer in Q3 2019 was Renaissance Technologies, an estimated $17.6K added.
- The largest NanoViricides seller in Q3 2019 was Geode Capital Management, an estimated $42K sold.
Based on aggregated 13F filings for Q3 2019.